Citalopram Tablet, Film Coated
Product Images NDC 0615-8141

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Citalopram (NDC 0615-8141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 1)

Chemical Structure (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 1)
Chemical structure diagram of Citalopram Hydrobromide, showing its molecular arrangement including aromatic rings, fluorine, nitrile group, and the hydrobromide salt form.*
FDA Label Image

Citalopram 10mg Bingo Card Label (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 2)

Citalopram 10mg Bingo Card Label (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 2)
Citalopram 10 mg film-coated tablets packaging label. The front label specifies 30 tablets per container, manufactured by Aurobindo, packaged by Vangard in Glasgow, KY. The label includes barcodes, lot number 8022, storage instructions at 20°-25°C, and states for institutional use only. Each tablet contains citalopram hydrobromide USP equivalent to 10 mg citalopram base.*
FDA Label Image

Citalopram 10mg Unit Dose Label (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 3)

Citalopram 10mg Unit Dose Label (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 3)
Label sheet for Citalopram Tablets USP 10 mg, film-coated oral tablets. The labels show the product name, strength (10 mg), NCS HealthCare of KY, LLC dba Vangard Labs as repackager in Glasgow, KY, lot number 8022, and barcodes for inventory control. The main label includes storage instructions, Rx-only status, quantity (30 tablets), manufacturing by Aurobindo, and reference to dosage information on the insert or label.*
FDA Label Image

Citalopram Tablet 20mg Bingo Card Label (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 4)

Citalopram Tablet 20mg Bingo Card Label (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 4)
Label for Citalopram Tablets USP 20 mg, film-coated oral tablets by NCS HealthCare of KY, LLC dba Vangard Labs. The label indicates packaging of 30 tablets per bottle, lot number 8023, manufactured by Aurobindo (NDC 65862-006-05). Storage instructions specify controlled room temperature of 20°- 25°C (68°-77°F).*
FDA Label Image

Citalopram Tablet 20mg Unit Dose Label (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 5)

Citalopram Tablet 20mg Unit Dose Label (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 5)
Label sheet for Citalopram Tablets USP 20 mg, film-coated oral tablets. The label includes multiple small dose labels with barcodes, lot number 8023, and manufacturer information showing the drug is repackaged by Vangard Labs in Glasgow, KY. The main label also displays storage instructions (20°-25°C), prescription status (Rx only), and manufacturer Aurobindo.*
FDA Label Image

Bingo Card Label (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 6)

Bingo Card Label (Citalopram 10mg 20mg 40mg Aurobindo 8022 8023 8141 6)
Citalopram Tabs USP 40 mg film-coated tablets packaging label. The label indicates the drug is citalopram hydrobromide equivalent to 40 mg citalopram base, with a quantity of 30 tablets. It is manufactured by Aurobindo and packaged by Vanguard Labs, Glasgow, KY. The label includes lot number 8141 and storage instructions for controlled room temperature. The Omnicare trademark is visible at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.